194 related articles for article (PubMed ID: 36258205)
1. Pan-cancer analysis of pre-diagnostic blood metabolite concentrations in the European Prospective Investigation into Cancer and Nutrition.
Breeur M; Ferrari P; Dossus L; Jenab M; Johansson M; Rinaldi S; Travis RC; His M; Key TJ; Schmidt JA; Overvad K; Tjønneland A; Kyrø C; Rothwell JA; Laouali N; Severi G; Kaaks R; Katzke V; Schulze MB; Eichelmann F; Palli D; Grioni S; Panico S; Tumino R; Sacerdote C; Bueno-de-Mesquita B; Olsen KS; Sandanger TM; Nøst TH; Quirós JR; Bonet C; Barranco MR; Chirlaque MD; Ardanaz E; Sandsveden M; Manjer J; Vidman L; Rentoft M; Muller D; Tsilidis K; Heath AK; Keun H; Adamski J; Keski-Rahkonen P; Scalbert A; Gunter MJ; Viallon V
BMC Med; 2022 Oct; 20(1):351. PubMed ID: 36258205
[TBL] [Abstract][Full Text] [Related]
2. Patterns in metabolite profile are associated with risk of more aggressive prostate cancer: A prospective study of 3,057 matched case-control sets from EPIC.
Schmidt JA; Fensom GK; Rinaldi S; Scalbert A; Appleby PN; Achaintre D; Gicquiau A; Gunter MJ; Ferrari P; Kaaks R; Kühn T; Boeing H; Trichopoulou A; Karakatsani A; Peppa E; Palli D; Sieri S; Tumino R; Bueno-de-Mesquita B; Agudo A; Sánchez MJ; Chirlaque MD; Ardanaz E; Larrañaga N; Perez-Cornago A; Assi N; Riboli E; Tsilidis KK; Key TJ; Travis RC
Int J Cancer; 2020 Feb; 146(3):720-730. PubMed ID: 30951192
[TBL] [Abstract][Full Text] [Related]
3. Association between pre-diagnostic circulating lipid metabolites and colorectal cancer risk: a nested case-control study in the European Prospective Investigation into Cancer and Nutrition (EPIC).
Harewood R; Rothwell JA; Bešević J; Viallon V; Achaintre D; Gicquiau A; Rinaldi S; Wedekind R; Prehn C; Adamski J; Schmidt JA; Jacobs I; Tjønneland A; Olsen A; Severi G; Kaaks R; Katzke V; Schulze MB; Prada M; Masala G; Agnoli C; Panico S; Sacerdote C; Jakszyn PG; Sánchez MJ; Castilla J; Chirlaque MD; Atxega AA; van Guelpen B; Heath AK; Papier K; Tong TYN; Summers SA; Playdon M; Cross AJ; Keski-Rahkonen P; Chajès V; Murphy N; Gunter MJ
EBioMedicine; 2024 Mar; 101():105024. PubMed ID: 38412638
[TBL] [Abstract][Full Text] [Related]
4. Prospective analysis of circulating metabolites and endometrial cancer risk.
Dossus L; Kouloura E; Biessy C; Viallon V; Siskos AP; Dimou N; Rinaldi S; Merritt MA; Allen N; Fortner R; Kaaks R; Weiderpass E; Gram IT; Rothwell JA; Lécuyer L; Severi G; Schulze MB; Nøst TH; Crous-Bou M; Sánchez MJ; Amiano P; Colorado-Yohar SM; Gurrea AB; Schmidt JA; Palli D; Agnoli C; Tumino R; Sacerdote C; Mattiello A; Vermeulen R; Heath AK; Christakoudi S; Tsilidis KK; Travis RC; Gunter MJ; Keun HC
Gynecol Oncol; 2021 Aug; 162(2):475-481. PubMed ID: 34099314
[TBL] [Abstract][Full Text] [Related]
5. Pre-diagnostic metabolite concentrations and prostate cancer risk in 1077 cases and 1077 matched controls in the European Prospective Investigation into Cancer and Nutrition.
Schmidt JA; Fensom GK; Rinaldi S; Scalbert A; Appleby PN; Achaintre D; Gicquiau A; Gunter MJ; Ferrari P; Kaaks R; Kühn T; Floegel A; Boeing H; Trichopoulou A; Lagiou P; Anifantis E; Agnoli C; Palli D; Trevisan M; Tumino R; Bueno-de-Mesquita HB; Agudo A; Larrañaga N; Redondo-Sánchez D; Barricarte A; Huerta JM; Quirós JR; Wareham N; Khaw KT; Perez-Cornago A; Johansson M; Cross AJ; Tsilidis KK; Riboli E; Key TJ; Travis RC
BMC Med; 2017 Jul; 15(1):122. PubMed ID: 28676103
[TBL] [Abstract][Full Text] [Related]
6. Circulating Lysophosphatidylcholines, Phosphatidylcholines, Ceramides, and Sphingomyelins and Ovarian Cancer Risk: A 23-Year Prospective Study.
Zeleznik OA; Clish CB; Kraft P; Avila-Pacheco J; Eliassen AH; Tworoger SS
J Natl Cancer Inst; 2020 Jun; 112(6):628-636. PubMed ID: 31593240
[TBL] [Abstract][Full Text] [Related]
7. Blood Metabolic Signatures of Body Mass Index: A Targeted Metabolomics Study in the EPIC Cohort.
Carayol M; Leitzmann MF; Ferrari P; Zamora-Ros R; Achaintre D; Stepien M; Schmidt JA; Travis RC; Overvad K; Tjønneland A; Hansen L; Kaaks R; Kühn T; Boeing H; Bachlechner U; Trichopoulou A; Bamia C; Palli D; Agnoli C; Tumino R; Vineis P; Panico S; Quirós JR; Sánchez-Cantalejo E; Huerta JM; Ardanaz E; Arriola L; Agudo A; Nilsson J; Melander O; Bueno-de-Mesquita B; Peeters PH; Wareham N; Khaw KT; Jenab M; Key TJ; Scalbert A; Rinaldi S
J Proteome Res; 2017 Sep; 16(9):3137-3146. PubMed ID: 28758405
[TBL] [Abstract][Full Text] [Related]
8. Metabolic signatures of greater body size and their associations with risk of colorectal and endometrial cancers in the European Prospective Investigation into Cancer and Nutrition.
Kliemann N; Viallon V; Murphy N; Beeken RJ; Rothwell JA; Rinaldi S; Assi N; van Roekel EH; Schmidt JA; Borch KB; Agnoli C; Rosendahl AH; Sartor H; Huerta JM; Tjønneland A; Halkjær J; Bueno-de-Mesquita B; Gicquiau A; Achaintre D; Aleksandrova K; Schulze MB; Heath AK; Tsilidis KK; Masala G; Panico S; Kaaks R; Fortner RT; Van Guelpen B; Dossus L; Scalbert A; Keun HC; Travis RC; Jenab M; Johansson M; Ferrari P; Gunter MJ
BMC Med; 2021 Apr; 19(1):101. PubMed ID: 33926456
[TBL] [Abstract][Full Text] [Related]
9. Are Metabolic Signatures Mediating the Relationship between Lifestyle Factors and Hepatocellular Carcinoma Risk? Results from a Nested Case-Control Study in EPIC.
Assi N; Thomas DC; Leitzmann M; Stepien M; Chajès V; Philip T; Vineis P; Bamia C; Boutron-Ruault MC; Sandanger TM; Molinuevo A; Boshuizen HC; Sundkvist A; Kühn T; Travis RC; Overvad K; Riboli E; Gunter MJ; Scalbert A; Jenab M; Ferrari P; Viallon V
Cancer Epidemiol Biomarkers Prev; 2018 May; 27(5):531-540. PubMed ID: 29563134
[No Abstract] [Full Text] [Related]
10. Prospective analysis of circulating metabolites and breast cancer in EPIC.
His M; Viallon V; Dossus L; Gicquiau A; Achaintre D; Scalbert A; Ferrari P; Romieu I; Onland-Moret NC; Weiderpass E; Dahm CC; Overvad K; Olsen A; Tjønneland A; Fournier A; Rothwell JA; Severi G; Kühn T; Fortner RT; Boeing H; Trichopoulou A; Karakatsani A; Martimianaki G; Masala G; Sieri S; Tumino R; Vineis P; Panico S; van Gils CH; Nøst TH; Sandanger TM; Skeie G; Quirós JR; Agudo A; Sánchez MJ; Amiano P; Huerta JM; Ardanaz E; Schmidt JA; Travis RC; Riboli E; Tsilidis KK; Christakoudi S; Gunter MJ; Rinaldi S
BMC Med; 2019 Sep; 17(1):178. PubMed ID: 31547832
[TBL] [Abstract][Full Text] [Related]
11. Identification of metabolites associated with prostate cancer risk: a nested case-control study with long follow-up in the Northern Sweden Health and Disease Study.
Röhnisch HE; Kyrø C; Olsen A; Thysell E; Hallmans G; Moazzami AA
BMC Med; 2020 Jul; 18(1):187. PubMed ID: 32698845
[TBL] [Abstract][Full Text] [Related]
12. Lifestyle correlates of eight breast cancer-related metabolites: a cross-sectional study within the EPIC cohort.
His M; Viallon V; Dossus L; Schmidt JA; Travis RC; Gunter MJ; Overvad K; Kyrø C; Tjønneland A; Lécuyer L; Rothwell JA; Severi G; Johnson T; Katzke V; Schulze MB; Masala G; Sieri S; Panico S; Tumino R; Macciotta A; Boer JMA; Monninkhof EM; Olsen KS; Nøst TH; Sandanger TM; Agudo A; Sánchez MJ; Amiano P; Colorado-Yohar SM; Ardanaz E; Vidman L; Winkvist A; Heath AK; Weiderpass E; Huybrechts I; Rinaldi S
BMC Med; 2021 Dec; 19(1):312. PubMed ID: 34886862
[TBL] [Abstract][Full Text] [Related]
13. Metabolic signature of healthy lifestyle and its relation with risk of hepatocellular carcinoma in a large European cohort.
Assi N; Gunter MJ; Thomas DC; Leitzmann M; Stepien M; Chajès V; Philip T; Vineis P; Bamia C; Boutron-Ruault MC; Sandanger TM; Molinuevo A; Boshuizen H; Sundkvist A; Kühn T; Travis R; Overvad K; Riboli E; Scalbert A; Jenab M; Viallon V; Ferrari P
Am J Clin Nutr; 2018 Jul; 108(1):117-126. PubMed ID: 29924298
[TBL] [Abstract][Full Text] [Related]
14. The blood metabolome of incident kidney cancer: A case-control study nested within the MetKid consortium.
Guida F; Tan VY; Corbin LJ; Smith-Byrne K; Alcala K; Langenberg C; Stewart ID; Butterworth AS; Surendran P; Achaintre D; Adamski J; Amiano P; Bergmann MM; Bull CJ; Dahm CC; Gicquiau A; Giles GG; Gunter MJ; Haller T; Langhammer A; Larose TL; Ljungberg B; Metspalu A; Milne RL; Muller DC; Nøst TH; Pettersen Sørgjerd E; Prehn C; Riboli E; Rinaldi S; Rothwell JA; Scalbert A; Schmidt JA; Severi G; Sieri S; Vermeulen R; Vincent EE; Waldenberger M; Timpson NJ; Johansson M
PLoS Med; 2021 Sep; 18(9):e1003786. PubMed ID: 34543281
[TBL] [Abstract][Full Text] [Related]
15. Metabolic perturbations prior to hepatocellular carcinoma diagnosis: Findings from a prospective observational cohort study.
Stepien M; Keski-Rahkonen P; Kiss A; Robinot N; Duarte-Salles T; Murphy N; Perlemuter G; Viallon V; Tjønneland A; Rostgaard-Hansen AL; Dahm CC; Overvad K; Boutron-Ruault MC; Mancini FR; Mahamat-Saleh Y; Aleksandrova K; Kaaks R; Kühn T; Trichopoulou A; Karakatsani A; Panico S; Tumino R; Palli D; Tagliabue G; Naccarati A; Vermeulen RCH; Bueno-de-Mesquita HB; Weiderpass E; Skeie G; Ramón Quirós J; Ardanaz E; Mokoroa O; Sala N; Sánchez MJ; Huerta JM; Winkvist A; Harlid S; Ohlsson B; Sjöberg K; Schmidt JA; Wareham N; Khaw KT; Ferrari P; Rothwell JA; Gunter M; Riboli E; Scalbert A; Jenab M
Int J Cancer; 2021 Feb; 148(3):609-625. PubMed ID: 32734650
[TBL] [Abstract][Full Text] [Related]
16. Circulating amino acid levels and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition and UK Biobank cohorts.
Rothwell JA; Bešević J; Dimou N; Breeur M; Murphy N; Jenab M; Wedekind R; Viallon V; Ferrari P; Achaintre D; Gicquiau A; Rinaldi S; Scalbert A; Huybrechts I; Prehn C; Adamski J; Cross AJ; Keun H; Chadeau-Hyam M; Boutron-Ruault MC; Overvad K; Dahm CC; Nøst TH; Sandanger TM; Skeie G; Zamora-Ros R; Tsilidis KK; Eichelmann F; Schulze MB; van Guelpen B; Vidman L; Sánchez MJ; Amiano P; Ardanaz E; Smith-Byrne K; Travis R; Katzke V; Kaaks R; Derksen JWG; Colorado-Yohar S; Tumino R; Bueno-de-Mesquita B; Vineis P; Palli D; Pasanisi F; Eriksen AK; Tjønneland A; Severi G; Gunter MJ
BMC Med; 2023 Feb; 21(1):80. PubMed ID: 36855092
[TBL] [Abstract][Full Text] [Related]
17. Circulating Metabolites Associated with Alcohol Intake in the European Prospective Investigation into Cancer and Nutrition Cohort.
van Roekel EH; Trijsburg L; Assi N; Carayol M; Achaintre D; Murphy N; Rinaldi S; Schmidt JA; Stepien M; Kaaks R; Kühn T; Boeing H; Iqbal K; Palli D; Krogh V; Tumino R; Ricceri F; Panico S; Peeters PH; Bueno-de-Mesquita B; Ardanaz E; Lujan-Barroso L; Quirós JR; Huerta JM; Molina-Portillo E; Dorronsoro M; Tsilidis KK; Riboli E; Rostgaard-Hansen AL; Tjønneland A; Overvad K; Weiderpass E; Boutron-Ruault MC; Severi G; Trichopoulou A; Karakatsani A; Kotanidou A; Håkansson A; Malm J; Weijenberg MP; Gunter MJ; Jenab M; Johansson M; Travis RC; Scalbert A; Ferrari P
Nutrients; 2018 May; 10(5):. PubMed ID: 29789452
[TBL] [Abstract][Full Text] [Related]
18. Models including plasma levels of sphingomyelins and phosphatidylcholines as diagnostic and prognostic biomarkers of endometrial cancer.
Knific T; Vouk K; Smrkolj Š; Prehn C; Adamski J; Rižner TL
J Steroid Biochem Mol Biol; 2018 Apr; 178():312-321. PubMed ID: 29360580
[TBL] [Abstract][Full Text] [Related]
19. Prepregnancy Body Mass Index and Lipoprotein Fractions are Associated with Changes in Women's Serum Metabolome from Late Pregnancy to the First Months of Postpartum.
Padilha M; Ferreira ALL; Normando P; Freire SDSR; Fiamoncini J; Brennan L; Yin X; Kac G
J Nutr; 2023 Jan; 153(1):56-65. PubMed ID: 36913479
[TBL] [Abstract][Full Text] [Related]
20. Plasma metabolites associated with type 2 diabetes in a Swedish population: a case-control study nested in a prospective cohort.
Shi L; Brunius C; Lehtonen M; Auriola S; Bergdahl IA; Rolandsson O; Hanhineva K; Landberg R
Diabetologia; 2018 Apr; 61(4):849-861. PubMed ID: 29349498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
